Table 1.
Instruments per measurement moment.
| Instrument | Screening | T0a | T1b (3 month) | T2 (6 month) | T3 (12 month) |
| Anxiety symptom severity (GAD-7c) | ✓d | ✓ | ✓ | ✓ | ✓ |
| Positive mental health (MHC-SFe) | —f | ✓ | ✓ | ✓ | ✓ |
| Depression symptom severity (PHQ-9g) | ✓ | ✓ | ✓ | ✓ | ✓ |
| Presence of psychiatric disordersh (MINI-Plusi) | ✓ | ✓ | ✓ | — | ✓ |
| Functional impairmenth (SDSj) | ✓ | ✓ | ✓ | — | ✓ |
| Treatment satisfaction (CSQ-8k) | — | — | ✓ | — | — |
aT0: baseline.
bT1: posttreatment.
cGAD-7: Generalized Anxiety Disorder-7.
dIndicates that the instrument was used at the specified measurement moment.
eMHC-SF: Mental Health Continuum-Short Form.
fIndicates that the instrument was not used at the specified measurement moment.
gPHQ-9: Patient Health Questionnaire-9.
hAssessed during telephone interviews by trained research assistants. Scores on these measures obtained during screening are analyzed as part of baseline.
iMINI-Plus: Mini-International Neuropsychiatric Interview-Plus.
jSDS: Sheehan Disability Scale.
kCSQ-8: Client Satisfaction Questionnaire-8.